1
Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer
Condition(s):Breast Cancer; Castration-resistant Prostate CancerLast Updated:May 11, 2023Recruiting